Sanofi (SNY) Short-term Investments (2009 - 2021)

Sanofi has disclosed Short-term Investments across 13 years of filings, most recently posting $12.5 million for Q4 2021.

• In Q4 2021, Short-term Investments fell 93.18% year-over-year to $12.5 million; the TTM figure through Dec 2021 stood at $12.5 million (down 93.18% YoY), while the FY2021 annual figure was $12.9 million, down 92.64% from the prior year.
• Short-term Investments came in at $12.5 million for Q4 2021 at Sanofi, down from $182.9 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $227.1 million in Q4 2018 to a low of $12.5 million in Q4 2021.
• Average Short-term Investments over 5 years is $132.0 million, with a median of $147.0 million recorded in 2019.
• Year-over-year, Short-term Investments soared 170.86% in 2017 and sank 93.18% in 2021.
• Over 5 years, Short-term Investments stood at $90.7 million in 2017, then jumped by 150.53% to $227.1 million in 2018, then slumped by 35.28% to $147.0 million in 2019, then climbed by 24.42% to $182.9 million in 2020, then plunged by 93.18% to $12.5 million in 2021.
• Per Business Quant data, the three most recent Short-term Investments figures were $12.5 million in Q4 2021, $182.9 million in Q4 2020, and $147.0 million in Q4 2019.